HR20013 / Jiangsu Hengrui Pharma  >>  Phase 3
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
HR20013 / Jiangsu Hengrui Pharma
NCT05509634: Clinical Study of HR20013 for Injection in Patients With Malignant Solid Tumors

Completed
3
754
RoW
HR20013 for injection;dexamethasone, fosaprepitant dimeglumine for injection;palonosetron hydrochloride injection;dexamethasone
Fujian Shengdi Pharmaceutical Co., Ltd.
Prevention of Nausea and Vomiting Caused by Highly Emetogenic Chemotherapy
06/23
08/23

Download Options